Analyst Consensus ?
ConsensusBuy44 ratings
Bullish2352.3%
Neutral2045.4%
Bearish12.3%
FN2 Earnings Intelligence
Incyte Corporation complete analyst coverage
Incyte Corporation (INCY) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$122.99Current
$48Low
$104.92Average
$200High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 29, 2026 |
| HC Wainwright & Co. | Buy | Buy | Maintain | Jul 29, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 29, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 29, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 29, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 23, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 23, 2026 |
| UBS | Neutral | Neutral | Maintain | Jun 26, 2026 |
| Truist Securities | Hold | Hold | Maintain | Jun 22, 2026 |
| Stifel | Buy | Buy | Maintain | Apr 29, 2026 |
| Oppenheimer | Perform | Perform | Maintain | Apr 29, 2026 |
| Jefferies | Hold | Buy | Downgrade | Mar 16, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Mar 5, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Feb 11, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Feb 6, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jan 13, 2026 |
| Mizuho | Outperform | Neutral | Upgrade | Dec 8, 2025 |
| B of A Securities | Buy | Buy | Maintain | Sep 4, 2025 |
| Citigroup | Buy | Buy | Maintain | Jul 30, 2025 |
| William Blair | Market Perform | Outperform | Downgrade | Mar 18, 2025 |
| Citizens Capital Markets | Market Perform | Market Perform | Maintain | Mar 11, 2025 |
| JMP Securities | Market Perform | Market Perform | Maintain | Feb 11, 2025 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Jan 10, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 30, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Aug 1, 2024 |
| Leerink Partners | Outperform | Market Perform | Upgrade | Dec 13, 2023 |
| SVB Leerink | Underperform | Underperform | Maintain | Mar 20, 2023 |
| Credit Suisse | Buy | Buy | Maintain | Feb 16, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 8, 2023 |
| Benchmark | Buy | Hold | Upgrade | Jul 20, 2021 |
| Guggenheim Securities | Neutral | Buy | Downgrade | Jan 2, 2020 |
| Nomura | Buy | Buy | Maintain | Jul 31, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Apr 11, 2019 |
| Argus Research | Buy | Buy | Maintain | Feb 25, 2019 |
| Argus | Buy | Buy | Maintain | Feb 25, 2019 |
| Gabelli & Co. | Buy | Hold | Upgrade | Jan 24, 2019 |
| Leerink Swann | Perform | Market Perform | Maintain | Sep 25, 2018 |
| Raymond James | Outperform | Market Perform | Upgrade | Sep 11, 2017 |
| PiperJaffray | Neutral | Overweight | Downgrade | Apr 17, 2017 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Aug 5, 2016 |
| Brean Capital | Buy | Buy | Maintain | Feb 12, 2016 |
| Bank of America | Buy | Buy | Maintain | May 29, 2015 |
| Lazard | Buy | Neutral | Upgrade | Jan 14, 2013 |
| Canaccord Genuity | Buy | Buy | Maintain | Apr 26, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $122.99. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| RBC Capital | Brian Abrahams | $109 | $126.69 | -11.4% | Jul 29, 2026 |
| BMO Capital | Analyst unavailable | $130 | $128.83 | +5.7% | Jul 29, 2026 |
| Guggenheim | Whitney Ljem | $150 | $129.93 | +22.0% | Jul 29, 2026 |
| Morgan Stanley | Analyst unavailable | $119 | $129.93 | -3.2% | Jul 29, 2026 |
| H.C. Wainwright | Analyst unavailable | $150 | $129.93 | +22.0% | Jul 29, 2026 |
| Barclays | Analyst unavailable | $139 | $129.93 | +13.0% | Jul 29, 2026 |
| Stifel Nicolaus | Stephen Willey | $145 | $130.08 | +17.9% | Jul 28, 2026 |
| Oppenheimer | Analyst unavailable | $120 | $130.08 | -2.4% | Jul 28, 2026 |
| Morgan Stanley | Analyst unavailable | $104 | $116.12 | -15.4% | Jul 23, 2026 |
| Barclays | Analyst unavailable | $134 | $114.23 | +9.0% | Jul 14, 2026 |
| BMO Capital | Analyst unavailable | $112 | $115.04 | -8.9% | Jul 13, 2026 |
| RBC Capital | Analyst unavailable | $99 | $115.62 | -19.5% | Jul 7, 2026 |
| UBS | Analyst unavailable | $113 | $107.53 | -8.1% | Jun 26, 2026 |
| Truist Financial | Analyst unavailable | $105 | $103.21 | -14.6% | Jun 22, 2026 |
| BMO Capital | Evan David Seigerman | $94 | $98.22 | -23.6% | Jun 22, 2026 |
| H.C. Wainwright | Mitchell Kapoor | $140 | $103.23 | +13.8% | Jun 10, 2026 |
| Stifel Nicolaus | Stephen Willey | $123 | $103.07 | +0.0% | Jun 9, 2026 |
| Oppenheimer | Jay Olson | $107 | $100.64 | -13.0% | Jun 8, 2026 |
| Bernstein | Analyst unavailable | $99 | $97.41 | -19.5% | May 21, 2026 |
| Oppenheimer | Analyst unavailable | $90 | $97.74 | -26.8% | Apr 29, 2026 |
| Barclays | Analyst unavailable | $117 | $101.16 | -4.9% | Feb 18, 2026 |
| Morgan Stanley | Analyst unavailable | $102 | $98.45 | -17.1% | Feb 11, 2026 |
| Stifel Nicolaus | Stephen Willey | $120 | $100.05 | -2.4% | Feb 11, 2026 |
| Piper Sandler | Allison Bratzel | $110 | $102.76 | -10.6% | Feb 6, 2026 |
| H.C. Wainwright | Analyst unavailable | $135 | $102.6 | +9.8% | Feb 5, 2026 |
| Barclays | Analyst unavailable | $116 | $100.92 | -5.7% | Feb 4, 2026 |
| Wells Fargo | Analyst unavailable | $107 | $106.21 | -13.0% | Jan 20, 2026 |
| Goldman Sachs | Analyst unavailable | $90 | $110.57 | -26.8% | Jan 8, 2026 |
| Stifel Nicolaus | Stephen Willey | $119 | $101.79 | -3.2% | Jan 5, 2026 |
| Truist Financial | Srikripa Devarakonda | $103 | $100.91 | -16.3% | Dec 24, 2025 |
| Morgan Stanley | Analyst unavailable | $92 | $96.46 | -25.2% | Dec 8, 2025 |
| Wells Fargo | Derek Archila | $116 | $102.52 | -5.7% | Dec 8, 2025 |
| Mizuho Securities | Salim Syed | $121 | $102.52 | -1.6% | Dec 8, 2025 |
| Barclays | Analyst unavailable | $115 | $102.06 | -6.5% | Nov 24, 2025 |
| Piper Sandler | Allison Bratzel | $102 | $102.35 | -17.1% | Nov 4, 2025 |
| Truist Financial | Analyst unavailable | $93 | $90.35 | -24.4% | Oct 29, 2025 |
| RBC Capital | Analyst unavailable | $84 | $91.65 | -31.7% | Oct 29, 2025 |
| Wells Fargo | Derek Archila | $97 | $92.02 | -21.1% | Oct 29, 2025 |
| Barclays | Peter Lawson | $101 | $91.65 | -17.9% | Oct 29, 2025 |
| UBS | Analyst unavailable | $68 | $77.55 | -44.7% | Jul 30, 2025 |
| RBC Capital | Analyst unavailable | $67 | $67.26 | -45.5% | Jun 23, 2025 |
| Guggenheim | Analyst unavailable | $92 | $60 | -25.2% | Mar 18, 2025 |
| Seaport Global | Aaron Kessler | $200 | $73 | +62.6% | Oct 30, 2024 |
| Oppenheimer | Jay Olson | $82 | $73.6 | -33.3% | Oct 30, 2024 |
| Citigroup | David Lebowitz | $97 | $73.6 | -21.1% | Oct 30, 2024 |
| Jefferies | Kelly Shi | $84 | $73.6 | -31.7% | Oct 29, 2024 |
| Bank of America Securities | Tazeen Ahmad | $90 | $73.6 | -26.8% | Oct 29, 2024 |
| Wolfe Research | Andy Chen | $84 | $66.1 | -31.7% | Sep 30, 2024 |
| Bank of America Securities | Tazeen Ahmad | $68 | $63.56 | -44.7% | Sep 16, 2024 |
| Goldman Sachs | Salveen Richter | $60 | $63.56 | -51.2% | Sep 16, 2024 |
| Citigroup | David Lebowitz | $92 | $62.16 | -25.2% | Aug 18, 2024 |
| RBC Capital | Brian Abrahams | $66 | $65.7 | -46.3% | Jul 31, 2024 |
| Oppenheimer | Jay Olson | $81 | $68.57 | -34.1% | Jul 26, 2024 |
| BMO Capital | Evan Seigerman | $48 | $60.87 | -61.0% | Jul 2, 2024 |
| Deutsche Bank | James Shin | $55 | $58.2 | -55.3% | May 23, 2024 |
| BMO Capital | Evan David Seigerman | $52 | $52.05 | -57.7% | Apr 30, 2024 |
| Argus Research | Jasper Hellweg | $70 | $50.48 | -43.1% | Apr 25, 2024 |
| Cowen & Co. | Analyst unavailable | $100 | $80.38 | -18.7% | Feb 8, 2023 |
| Wells Fargo | Analyst unavailable | $75 | $79.74 | -39.0% | Jan 3, 2023 |
| Oppenheimer | Jay Olson | $98 | $73.99 | -20.3% | Aug 15, 2022 |
| Leerink Partners | Analyst unavailable | $63 | $81.36 | -48.8% | Jul 20, 2022 |
| Morgan Stanley | Analyst unavailable | $76 | $78.94 | -38.2% | Apr 20, 2022 |
| BMO Capital | Evan Seigerman | $75 | $70.07 | -39.0% | Feb 8, 2022 |
| Guggenheim | Michael Schmidt | $104 | $73.97 | -15.4% | Jan 3, 2022 |
| Goldman Sachs | Salveen Richter | $136 | $66.74 | +10.6% | Nov 24, 2021 |
| Oppenheimer | Jay Olson | $109 | $66.79 | -11.4% | Nov 3, 2021 |
| Cantor Fitzgerald | Alethia Young | $79 | $65.56 | -35.8% | Oct 15, 2021 |
| Ladenburg Thalmann & Co. | Aydin Huseynov | $89 | $69.78 | -27.6% | Sep 23, 2021 |
Track every rating change on INCY the moment it posts. Free to start.
Start free